CEO PROVIDES UPDATE FOR NEW WEBSITE AND UPCOMING PRODUCTS AND
SERVICES.
Freehold, NJ – October 27, 2014 – MEDIFIRST SOLUTIONS, INC.
(OTCQB:
MFST) would like to take this opportunity to update
shareholders on exciting new company events and developments.
Medifirst has created a new division to address the Ebola virus and
potential outbreaks across the country. The Ebola virus is one of
the greatest possible threats to ever hit the United States. In
just two months, the Ebola outbreak that has spiraled out of
control in West Africa and is spreading to the U.S., could see
10,000 new cases every week, according to the World Health
Organization. The latest projection outlines a dire situation, as
the deadliest Ebola outbreak in history has health officials across
the globe scrambling and struggling to identify, treat and prevent
the disease that has no cure or vaccine.
Medifirst is pleased to announce that is has acquired the domain
www.ebolasafety.com. The website, currently being
developed, will focus on industry products, services and education.
Commented CEO Bruce J. Schoengood, “I believe there should be a
tremendous demand for safety products and education if the Ebola
crisis continues to worsen here in the states. Until the
virus is stopped in its tracks in West Africa, it poses a serious
risk to all countries and especially the U.S. as its healthcare
system and its ability to treat and fight the virus gives great
incentive to anyone exposed to enter our country and seek
treatment. The CDC (Center for Disease Control) as well as
local hospitals and officials have struggled with determining
uniform protocol and procedures in dealing with just a handful of
patients. Even a very small outbreak could cause complete
chaos.”
Ebola safety is first and foremost on the minds of all
Americans. Medifirst plans to sell safety related products to
the public as well as offer free education information and related
updates. Additionally, the company is in discussion to sell it’s
own label of immunity boosters. Said Dr. Ronald Rubin, Chief
Medical Officer, “The first line of defense for any virus is to
have your immune system boosted up and working at full strength.
With so many people deficient in vitamins and minerals having the
right supplement will have a positive impact in fighting off
viruses.”
The CDC has been every forthright in announcing the need to
develop and distribute a wide array of educational materials
including industry standard protocols for the healthcare community
and civilian population. Combined with all the hospitals and
healthcares services, we anticipate that there will be a massive
demand for print and digital services. Having many years experience
in Medical Education and publishing, CEO Bruce Schoengood is
spearheading a graphics and marketing division to offer and bid its
services and expertise to the government and healthcare
industry.
Medifirst previously announced that it had agreed in principle
to acquire a New Jersey based medical practice that specializes in
anti-aging and cosmetic procedures. The practice has multiple
locations and has been in business for six years. We anticipate an
announcement on the acquisition within the next 10 business
days.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is
headquartered in New Jersey. The company seeks innovative medical
and healthcare products and technologies which are targeted to both
medical and healthcare professionals as well as everyday consumers.
Medifirst Solutions is developing and establishing both consumer
and professional medical and cliental to be used as a pipeline that
will allow for distribution of our new products and services. For
more details visit www.medifirstsolutions.com for more
information.
Forward-Looking Statements: The statements in this press
release that relate to the company's expectations with regard to
the future impact on the company's results from new products in
development are forward-looking statements, and may involve risks
and uncertainties, some of which are beyond our control. Such
risks and uncertainties are described in greater detail in our
filings with the U.S. Securities and Exchange Commission.
Since the information in this press release may contain statements
that involve risk and uncertainties and are subject to change at
any time, the company's actual results may differ materially from
expected results. We make no commitment to disclose any
subsequent revisions to forward-looking statements.
Contact: Investor Relations
Phone: (732) 786-8044
Email: info@medifirstsolutions.com
Website: www.medifirstsolutions.com